Anakinra in mutation-negative CINCA syndrome

By Callejas José Luis   Oliver Javier   Martín Javier   Ortego Norberto  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 576-577

Springer Publishing Company

Access to resources Recommend Favorite

Antiphospholipid Syndrome as a Neurological Disease

By  

Current Rheumatology Reviews, Vol. 6, Iss. 1, 2010-02 ,pp. : 12-17

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical course of a child with CINCA/NOMID syndrome improved during and after treatment with thalidomide

By Kallinich T.   Hoffman H. M.   Roth J.   Keitzer R.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 3, 2005-06 ,pp. : 246-249

Informa Healthcare

Access to resources Recommend Favorite

Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome

By Kashiwagi Yasuyo   Kawashima Hisashi   Nishimata Shigeo   Nagao Ryuhei   Watanabe Kiyoko   Takekuma Kouji   Hoshika Akinori  

Clinical Rheumatology, Vol. 27, Iss. 2, 2008-02 ,pp. : 277-279

Springer Publishing Company

Access to resources Recommend Favorite

Improvement of serum bilirubin levels after venesection in a patient with Dubin-Johnson syndrome and HCV-positive chronic liver disease

By Machida Ikuo   Wakusawa Shinya   Hayashi Hisao   Suzuki Satoshi   Yano Motoyoshi  

Journal of Gastroenterology, Vol. 39, Iss. 9, 2004-09 ,pp. : 896-899

Springer Publishing Company

Access to resources Recommend Favorite